Dutasteride (brand name Avodart) is a 5-alpha reductase inhibitor originally approved by the FDA for benign prostatic hyperplasia, an enlarged prostate condition
Initial appetite control and energy improvements may be observed within 1-2 weeks, while noticeable weight loss and improved glucose control often occur within 4-8 weeks
Roerink noted that traits consumers most commonly ask for are healthy inclusions, fortification and smaller portions
Toward this end, NCLs blueprint identifies nine priorities for action: Make Combating Infodemics a National Priority The growing threat of misinformation requires a unified national response, and NCLs anti-disinformation initiative, the Weight Truth, can be the model for educating consumers and being a platform for clinicians, advocates, and policymakers to advance policy changes to protect consumers
Eating became functional rather than emotional
Semaglutide and tirzepatide both regulate appetite and blood sugar, but tirzepatide targets an additional metabolic pathway that sets it apart
